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This paper presents a Markov model of the transmission and development 
of HIV and AIDS. The Markov model is used to derive functions needed in the 
calculation of disability insurance premiums, reserves, and cash flows. An 
application to health insurance and disability insurance is provided. 
Key words and phrases: permanent health insurance, transition probabilities, 
premiums, cash flows 
1 Introduction 
In the late 1980s the Institute of Actuaries AIDS working party de-
veloped a Markov model of the transmission and spread of AIDS among 
(only) male homosexuals in the United Kingdom; see Daykin et al. (1988a, 
1988b, 1990), This model is, in many respects, similar to other mathe-
matical models proposed for the transmission and spread of AIDS.l 
* Steven Haberman, Ph.D., F.I.A., is professor of actuarial science and dean of the 
School of Mathematics, Statistics and Actuarial Science at City University, London. He 
obtained his masters degree in'mathematics from Cambridge University and a Ph.D. 
in actuarial science from City University. Professor Haberman qualified as a Fellow of 
the Institute of Actuaries in 1975, winning the Burn Prize. He has published widely in 
actuarial and related fields, and his present research interests include mortality and 
morbidity modeling, and pension funding. 
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tThis research work was performed under research contract SPES-CT91-0063. 
IThe use of Markov models in actuarial mathematics has been proposed by a num-
ber of authors; for example, see Waters (1984, 1989), Amsler (1988), Haberman (1988, 
1992), Hoem (1988), Wilkie (1988), Norberg (1988), Ramsay (1989), Continuous Mortal-
ity Investigation Report No. 12 (1991), Pitacco (1993), and Jones (1994). For a review 
of the mathematical models proposed for the transmission and spread of AIDS, see 
Haberman (1990). Markov models and their applications to life contingencies are in-
cluded in the Institute and Faculty of Actuaries' syllabus for their professional subject, 
actuarial mathematics (Subject D). See Chadburn et al. (1993). 
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The emphasis of actuarial models of HIV / AIDS has been the impact 
of HIV and AIDS on life insurance underwriting, life insurance premi-
ums, reserving, and, to a lesser extent, health insurance and pension 
provision. The Institute of Actuaries working party's model attempts 
(in their own words): "(t)o show the potential impact of HIV on mortal-
ity and morbidity and the implications for the use of existing actuarial 
bases and standard tables for premium rating and reserving". To ac-
complish this, the Institute of Actuaries working party developed an 
age-specific model that allows them to use the type of data that nor-
mally are available to an insurance company to do the following: (i) to 
consider the progress of individuals of a given age and gender through 
future calendar years, (ii) to consider the longer-term trend in transmis-
sion, and (iii) to produce numerical results (although not necessarily by 
analytical means). For these reasons, equilibrium models are of less 
interest. 
The objective of this paper is to develop a modified version of the In-
stitute of Actuaries AIDS working party model. This model then is used 
to determine the permanent health insurance (PHI) valuation functions 
needed for the calculation of net premiums and policy values. Exam-
ples are given to illustrate formulae and calculations that could be of 
value in supporting actuarial decisions on pricing and reserving for PHI. 
In practice, pricing is based on cash-flow models (as well as on present 
value considerations) using realistic assumptions and allowing for the 
cost of capital tied up in the establishment of reserves on a more strin-
gent basis. A brief discussion of the equations needed for cash-flow 
and profit-testing models is provided in Section 6. 
The approach advocated in this paper permits the development of 
partial derivatives of the key valuation functions so that their sensi-
tivities to changes in the underlying parameters (e.g., force of interest, 
transition intensities) can be measured explicitly. This information is 
intended to supplement the calculation of sensitivities based on inten-
sive computer-based calculations. An advantage of making these sim-
plified assumptions to the Institute of Actuaries AIDS working party's 
model is that the resulting simplified model provides an approxima-
tion to the transmission of HIV and development of AIDS without the 
restrictions to the male homosexual population. 
The paper is organized as follows: Section 2 provides a brief descrip-
tion of the Institute of Actuaries AIDS working party model. Section 3 
describes the modified model used throughout the rest of the paper. 
Section 4 describes the basics of PHI in the United Kingdom, while Sec-
tion 5 provides expressions for several PHI valuation functions. Section 
6 provides a mathematical description of the expected emerging costs 
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and cash flows. Finally, Section 7 provides various extensions and mod-
ifications to the model described in Section 3. 
2 Institute of Actuaries AIDS Working Party Model 
The Institute of Actuaries AIDS working party model is a Markov 
model of the transmission and the progression of HIV among male 
homosexuals only, with each cohort (of a single age) treated indepen-
dently. The model assumes that infection occurs from contact between 
two individuals homosexuals within a single age group.2 This assump-
tion is artificial, but if infections between those of different ages bal-
ance, it may be a reasonable representation of reality. The transition 
intensities between states are allowed to vary with attained age and 
time. The model allows for immigration of susceptibles and for normal 
mortality as well as extra mortality from AIDS. 
The AIDS working party made several other simplifying assump-
tions, including the follOWing: 
• That all males described as being at risk of infection behave in the 
same manner at anyone time. As a result, the probability of infec-
tion depends on the age of the individual at risk and the particular 
calendar year, but not on any subdivision according to frequency 
of sexual contact or frequency of change of sexual partner. 
• There are six states. The members of one cohort at age x may 
be in anyone of the six discrete states indicated in Figure 1. Five 
of these are live states: clear, at risk, immune, positive, and sick 
from AIDS. The sixth state is the dead state. 
Those in the clear state are those whose sexual activity puts them 
at no risk of becoming infected with HIV. They form the normal 
pre-AIDS population for comparative purposes. Those at risk are 
at risk of acquiring HIV infection through sexual contact with in-
fected persons. Those in the immune state are assumed to have 
acquired HIV infection and to be infectious, but to be immune 
from becoming sick from AIDS or dying from AIDS. Those in the 
positive state are HIV seropositive, but not yet sick from AIDS; 
they are infectious and not immune. 
• It is possible to distinguish those who are HIV seropositive from 
those who are sick from AIDS. In reality, there are several stages 
2This model ignores the possibility of heterosexual transmission of the disease and 
the effects of risk factors such as intravenous drug use and geographic location. 
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Figure 1 
Institute of Actuaries AIDS Working Party Model 
Sick from 
HIV + (1) AIDS (2) 
Dead (5) 
in the transition from HIY infection to death from AIDS. Those 
who are suffering from AIDS are highly infectious, but their sex-
ual activity may be reduced considerably. The model makes it 
possible to choose whether those sick from AIDS are treated as 
contributing to further infections or not . 
• The current age is part of the status and that transition intensi-
ties can vary by current age. In addition, because each age cohort 
(or year of birth cohort) is treated separately, each transition in-
tensity can be varied by calendar year; therefore, each cohort has 
its own set of transition intensities. Durations since entry to the 
states immune, positive, and sick from AIDS are also relevant to 
the transition intensities. 
Possible transitions are as shown in Figure 1. Those in any of the live 
states may die, and those who are sick from AIDS may die from AIDS or 
from causes other than AIDS. Those who are at risk may change their 
behavior and become clear, for example, by giving up sexual activity or 
by restricting themselves to one equally monogamous partner. There is 
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no representation in the model of transfer from clear to at risk. Those 
who are at risk may become infected; at that point, these persons im-
mediately are allocated either to the immune state or to the positive 
state in proportions that may depend on age (and on calendar year, 
although it seems unlikely that calendar year would exercise any influ-
ence). Those in the positive state may become sick from AIDS, if they 
do not die first. Infection is possible from the immunes, positives, and 
sick. 
In order not to increase the basic underlying numerical complexity 
inherent in the model, the Institute of Actuaries working party avoided 
introducing elements that depend on detailed assumptions about sex-
ual behaVior. 
The working party proceeded by establishing a complex series of or-
dinary and partial differential equations for the probabilities of survival 
in a state and of transition between states and then solving these equa-
tions by numerical methods, given assumptions about the form of the 
various transition intensities. In most applications, the working party 
considered the following functional forms for the transition intensities: 
• Transition from state 0 to state 1: Ao is a function of calendar 
time, attained age, and number of persons infected; 
• Transition from state 0 to state 3: Vo is a function of calendar 
time; 
• Transition from state 0 to state 4: A6 is zero; 
• Transition from state 1 to state 2: Ai is a function of duration in 
state 1; 
• Transition from state i to state 5: J1i is a function of attained age 
for i = 0 or 3 or a function of calendar time and attained age for 
i = 1,2. 
3 The Modified AIDS Model 
Given the complexity of the Institute of Actuaries AIDS working 
party model, Haberman (1992) suggested that it be modified along the 
lines described below so that Markov processes techniques can be ap-
plied. Figure 2 depicts the modified version of the model, with the 
identified states and the corresponding transition intensities. The ar-
rows indicate the directions of the transitions that are permitted in this 
model. 
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Figure 2 
Modified AIDS Model (Version 1) 
Clear ~ At Risk ~ HN+ -+- Sick from 
(3) 
""0 (0) -\ (1) A, AIDS (2) 
,vf] v /0 ,v)-<, 'v ;<-L 
Dead (4) 
The proposed model is a continuous time Markov process with con-
stant transition intensities. Thus, a person in state 0 is subject to a 
constant force of progression out of state 0 into state 1, out of state 
o into state 3, and to a constant force of mortality out of state 0 into 
state 4. For a person in state 1, the possible transitions are to states 2 
and 4. For a person in state 2 or 3, the transitions are to state 4 only. 
Once a life leaves a state, it cannot return to that state. The constant 
transition intensities are as depicted in Figure 2, i.e., 
Ai Transition intensity from state i to state i + 1, for i = 0,1; 
l1i Force of mortality in state i, for i = 0,1,2,3; and 
Vo Transition intensity from state 0 to state 3. 
Because the transition intensities remain constant while an individual 
is in any state, a memoryless property exists. The length of time spent 
in the current state has no effect on the future length of time that the 
person will remain in this state. 
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We now consider how the model of the Institute of Actuaries AIDS 
working party (as described in Section 2) has been modified to fit with 
these assumptions. 
• First, the immune state is removed. 
• Second, the viewpoint is changed from that of the population as 
a whole to that of an individual male at risk who is considered 
to progress from state to state over time. We are concerned not 
with the spread of HIV in a population, but with the outcome for 
a particular individual. 
• Third, it is assumed that all transition intensities are constants, 
independent of attained age, duration in current state, and sec-
ular time. We acknowledge that this assumption contradicts the 
arguments of Daykin et al. (1988a, 1990) that explain the impor-
tance of these variables, in particular attained age, to an actuarial 
assessment of the effects of HIV and AIDS on survival prospects. 
Two arguments support this seemingly extreme assumption: 
1. The magnitude of the AIDS-related transition intensities out-
weighs the normal age-related mortality risk. Many of the 
AIDS working party simulations assume intensities that do 
not vary with respect to age; 
2. The desire to reach some analytical results does require, at 
least initially, some heroic assumptions. We believe that the 
results are, nevertheless, of value in pricing and reserving. 
• Fourth, it is assumed that the transition intensity from the at risk 
state to the seropositive state is constant and does not depend 
on the numbers of persons infected. This again is a simplify-
ing assumption to keep the resulting mathematical manipulations 
tractable.3 As noted by Daykin et al. (1990), a constant transition 
intensity from at risk to seropositive would be consistent with the 
exponential development of new cases of AIDS in the early stages 
of the epidemic. 
An advantage to making these simplifying assumptions to the origi-
nal model is that the model is now flexible enough to approximate the 
transmission of HIV and the development of AIDS without the restric-
tion to the male homosexual population mentioned in Section 2. 
3To allow for the effect of heterogeneity of risk and behavioral change, it would be 
reasonable to postulate an intensity that decreases with time as the epidemic develops. 
This assumption is not pursued here on the grounds of mathematical tractability. 
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Given these assumptions, the next step is to determine the transi-
tion probabilities. To this end, let Pi} (t) be the transition probability 
that a life now in state i will be in state j at t years from now. There 
are a number of different ways to set up equations for the required 
transition probabilities. A common approach used by actuaries (for ex-
ample, Ramsay (1989), Haberman (1992), and Jones (1994)) is to use 
the Chapman-Kolmogorov backward system of difference-differential 
equations. Because the transition intensities are assumed to be con-
stant, we obtain simple recursive solutions to these equations.4 
Assume that insurance is issued to a life in state i at time of issue, 










Ao (e-lX1t _ e- lXot ) 
lXo - lXl 
_A--,,1'-(e-JJ2t _ e- lX1t ) 
lXl - JJ2 
AoAl [ t 
-(lXl - JJ2)e- lXO (lXo - lXd(lXo - JJ2)( lX l - JJ2) 
+ (lXo - JJ2)e- lX1t - (lXo - lXl)e-JJ2t] 
Vo (e-JJ3t _ e- lXot ) 









where lXo = Vo + JJo + Ao and lXl = Al + JJl. We note from the repre-
sentation of the model in Figure 2 that Pi} (t) = 0 for i < j and that 
P13(t) = P23(t) = O. 
The associated probabilities of dying (being in state 4) are given by 
the following expression: 
3 
P04 1 - L POj(t) 
j=o 
3 
P14 1 - L POj(t) 
j=l 
4For a thorough discussion of the Chapman-Kolmogorov backward system of 
difference-differential equations, see Cox and Miller (Chapter 4, 1965) or Karlin and 
Taylor (Chapter 4, 1975). 
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P24 1 - e-J1zt 
P34 1 - e-J13t • 
Alternatively, the equations for Pi} (t) can be obtained using matrix 
methods; see Cox and Miller (Chapter 4.5, 1965). 
4 Individual Permanent Health Insurance (PHI) 
Individual PHI policies are designed to provide a weekly or monthly 
income to an individual if he/she is prevented by sickness from work-
ing. In this sense, PHI policies provide disability income protection.s 
Policies are typically for a fixed term, usually ceasing at age 65 for males 
or age 60 for females. Once the insurance company has offered formally 
to provide the necessary cover and the first premium has been paid, the 
company cannot cancel the policy as long as the policyholder obeys the 
policy conditions, hence the name permanent health insurance.6 
Under the most common type of PHI policy, a weekly or monthly 
income is paid to the policyholder when he/she has been sick for longer 
than the deferred period'? The benefit continues to be paid until"the 
policyholder recovers or dies or until the age at which the policy term 
ceases. Because the insurer cannot cancel the policy, a policyholder 
who is sick permanently, or indefinitely, will receive the benefit until 
one of the above events occurs. With most poliCies, the premiums are 
waived while the income benefit is being paid. 
Some poliCies pay a benefit of a fixed level amount, while others pro-
vide a benefit that increases to protect the policyholder from inflation. 
There are various methods by which increases in benefit are provided, 
some of which are more effective than others. 
Another common feature in policy design is a benefit level that re-
duces with duration of the sickness claim. This is designed to encour-
age a return to work. The availability of the PHI benefit may lengthen the 
duration of sickness because of its effect on the minimum acceptable 
salary that would entice the sick individual to return to gainful employ-
ment (Le., the so-called reservation wage). We allow for the presence of 
such stepped benefits in our valuation formulae in a later section. 
SIn applying the model to disability insurance poliCies, it is assumed that at the start 
of the policy the individual policyholder is in state 0 and healthy and that the insurance 
company's underwriting or selection process ensures that this is true. 
6In the U.S. the descriptions noncancellable and guaranteed renewable are used. 
7The deferred period is the minimum period of time that the illness must last before 
the benefit begins. The deferred period is usually four, 13, or 26 weeks. 
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As PHI policies usually are affected to supplement the sickness bene-
fit available from an employer or the benefit payable from the national 
or state government (e.g., in the United Kingdom, the national insur-
ance scheme), the deferred period chosen by the policyholder tends to 
reflect the length of time after which these benefits reduce or (in the 
case of benefits from an employer) cease. The longer the deferred pe-
riod, the cheaper the cover and, hence, the lower the premium. Let us 
now consider the effect of introducing a deferred period of d years on 
the value of the policy. 
For the moment let us assume that a sickness claim is admitted only 
when full AIDS develops, i.e., the policyholder is in state 2. To calculate 
present values, we need the probability that an individual starting in 
state 0 is sick throughout the time interval (t - d, t), i.e., that the un-
derlying stochastic process is in state 2 throughout this time interval. 
In the absence of the deferred period, the probability that the policy-
holder is in state 2 at time t given that the policyholder was in state 0 at 
time 0 is P02 (t). It can be verified by appealing to the Markov property 
tha t P02 (t) can be written as 
P02(t) = f~ POdU)P22(t);).qdu. (9) 
We can adapt equation (9) for the presence of a deferred period. Let 
us define qd (t) to be the probability that a person in state 0 at time 
zero is in state 2 throughout the time interval [t - d, t]. Adapting the 
integral definition (9), we can write the following: 
qd(t) = f~-d POdU)P22(t - u)?qdu, for t > d. (10) 
If t :::; d, qd (t) = O. A more formal derivation of qd (t) is provided by Wa-
ters (1984). Such probabilities have been suggested for unemployment 
insurance by Haberman and Bloomfield (1990) and used extensively by 
eMIR (1991) for the calculation of PHI-based functions. 
To deal with sickness claims that are paid while the policyholder 
is in state 1 or state 2, let us define rd(t) to be the probability that a 
person in state 0 at time zero is in state 1 or state 2 throughout the 
time interval [t - d, tJ. Clearly, 
rt - d 
rd(t) = Jo POO(U)(Pll (t - u) + P12(t - u))i\odu, for t > d. (11) 
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Given the earlier results [equations (3) and (5)], it follows that equa-
tion (10) becomes: 
AOAle-J.l2 t [1 - e-(OQ-J.l2)(t-d) 1 - e-( OiO-J.l2)(t-d)] 
q,dt) = 
«Xo - (Xd «Xl - iJ2) «Xo - iJ2) 
(12) 
Similarly, from equations (I), (2), and (6), equation (11) becomes 
AO [A I e-J.l2 t (1 - e-(Oi l-J.l2)(t-d)) 
«Xo - (Xl) «Xl - iJ2) 
(iJl - iJ2)e- 0i1t (1 - e-( OiO-J.l2)(t-d))] 
+ . 
«XO - (Xl) 
(13) 
5 PHI Valuation Functions 
Following Daykin et al. (1988b), we recognize that a major difficulty 
in estimating the impact of HIV infection and AIDS on PHI business 
is knowing at what stage a PHI claim will be presented to the insurer. 
For the purposes of illustration of the methodology and the results, we 
consider here two extreme cases. 
Case 1: We assume that a claim only is admitted when full AIDS devel-
ops. In the case of a PHI policy with a d week deferred period, 
we assume that no benefit is payable until d weeks after AIDS has 
developed (Le., after entry to state 2). 
Case 2: We make the equally extreme assumption that claims are ad-
mitted on the basis of HIV seropositivity alone (Le., on entry to 
state 1) without requiring evidence of AIDS or any of the interme-
diate stages. 
Let A j (n, d) be the actuarial present value (under Case j) of a PHI 
benefit of one unit (per year) in an n year policy (with the n years mea-
sured from the inception of the policy) with deferred period of d, for 
j = 1,2. It follows that: 
Adn,d) f: e-8t qd(t)dt Case 1; 
AOAI [(al + a2 - a3)e-(O+J.l2)d - ale-(o+J.l2)n 
_a2 e-( OiO-J.l2)d e -(o+ Oio)n + a3e(Oil-J.l2)de-(o+0iJ}n] (14) 
fun e-otrd(t)dt Case 2; 
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Ao [AlaI (e-(o+fJ2)d - e-(O+fJ2)n) 
+ a3 {f.1I - /12 )(e-(o+cq)d _ e-(o+oC!)n) 
- (Ala4e«()(O-fJ2)d + as (/11 - /12)e«()(o-()(lld) 
x (e-(o+()(o)d _ e-(o+()(o)n)] (15) 
where the akS are constants such that their reciprocals are given by 
all (0<0 -/12)(0<1 - /12)(8 + /12) 
az1 (0<0 -/12)(0<0 - 0<1)(8 + 0<0) 
ail (0<1 -/12)(0<0 - 0<1)(8 + 0<1) 
a;j1 (0<1 -/12)(0<0 -/12)(8 + 0<0) 
as 1 (0<1 -/12)(0<0 - o<d(8 + 0<0). 
Given these results, it is possible to investigate the explicit forms for 
the partial derivatives of Al (n, d) and A2 (n, d) with respect to d. To 
illustrate, we present some numerical values for Adn, d) and A2 (n, d) 
based on equations (14) and (15) for different combinations of some of 
the key parameters. 
Following Daykin et al. (1990), we set /12 = 0.35 and /10 = /13 = 0.001 
throughout.8 We also set Vo = 0.10 and d = 0.07. Tables 1 to 3 present 
the magnitudes of Al (n, d) and A2 (11, d) for the values of Ao, AI, /11, n, 
and d shown. For convenience, we set Ao = Al in this presentation. The 
results indicate that Al (n, d) and A2 (n, d) both increase with increas-
ing 11, decreasing d, decreasing /11, and increasing Ao = AI. They further 
indicate the relative sensitivities of Al (11, d) and A2 (n, d) to changes 
in these parameters and that the ratio A1(n,d)/A2(n,d) decreases as 
Ao = Al increases. These results are as expected. 
We can compare these results with those given by Daykin et al. 
(1988b) for the discounted present value of additional sickness ben-
efits under a PHI policy allowing for the two extreme cases described 
above. Daykin et al. use different morbidity and mortality assumptions 
(intermediate between the sets underlying Tables 2 and 3). It is im-
possible to rerun their full model on modified assumptions; however, 
we can consider from their appendix tables the values of Al (n, d) and 
A2 (n, d) and the ratio of the present values under Cases 1 and 2 for 
comparison with Tables 1 through 3. The details appear in Table 4 for 
a deferred period of six months and two alternative terminating ages. 
BThe values /-10 = /-13 = 0.001 are approximately equivalent to the value of the force 
of mortality for a male age 30 to 34 according to English Life Table No 14. 
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Table 1 
Present Values of PHI Benefits: Ao = A, = 0.001 
Deferred Period: 3 Months 
Policy Terms {Years) 5 10 15 20 
100 AI 0.00077 0.00341 0.00655 0.00935 
100 A2 .764 2.442 3.673 4.842 
Ratio 992 716 561 518 
III = 0.01 
100 AI 0.00076 0.00332 0.00631 0.00889 
100 A2 0.752 2.172 3.511 4.569 
Ratio 989 654 566 514 
III = 0.05 
100 AI 0.00073 0.00299 0.00538 0.00721 
100A2 0.700 1.900 2.904 3.599 
Ratio 958 635 540 499 
Deferred Period: 6 Months 
Policy Terms {Years) 5 10 15 20 
100 AI 0.00061 0.00293 0.00576 0.00830 
100 A2 0.687 2.127 3.543 4.705 
Ratio 1130 726 615 567 
III = 0.01 
100 AI 0.00061 0.00286 0.00555 0.00790 
100 A2 0.675 2.059 3.381 4.432 
Ratio 1110 720 609 561 
III = 0.05 
100 AI 0.00058 0.00258 0.00474 0.00642 
100 A2 .623 1.788 2.776 3.465 
Ratio 1070 693 586 540 
The magnitude of Al (n, d) and A2(n, d) and the ratios are intermediate 
between those appearing in Tables 2 and 3 and display similar trends. 
In particular, we note the stability of the ratios as we consider different 
age ranges. Similarly, expressions for the present value of premiums 
and expenses can be developed, including the value of expenses related 
to the timing of the payment of the sickness benefit. Also, allowance 
can be made for a waiver of premium benefits and for stepped sickness 
benefits, i.e., a level of sickness income that depends on the current 
duration of sickness. 
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Table 2 
Present Value of PHI Benefits: Ao = Al = 0.01 
Deferred Period: 3 Months 
Policy Terms (Years) 5 10 15 20 
100 Al 0.0755 0.3257 0.6130 0.8586 
100 A2 7.507 21.567 34.655 44.890 
Ratio 99.5 66.2 56.5 52.3 
III = 0.01 
100 Al 0.0746 0.3178 0.5906 0.8168 
100A2 7.385 20.911 33.149 42.418 
Ratio 99.0 65.8 56.1 51.9 
III = 0.05 
100 Al 0.0710 0.2863 0.5049 0.6660 
100 A2 6.784 18.320 27.515 33.621 
Ratio 96.9 64.0 54.4 50.5 
Deferred Period: 6 Months 
Policy Terms (Years) 5 10 15 20 
100 Al 0.0600 .2802 .5396 .7629 
100 A2 6.745 20.458 33.405 43.584 
Ratio 112 73.0 61.9 57.1 
III = 0.01 
100 Al 0.0593 0.2736 0.5201 0.7265 
100 A2 6.625 19.806 31.904 41.117 
Ratio 112 72.3 61.3 56.6 
III = 0.05 
100 Al 0.0566 0.2472 0.4458 0.5937 
100 A2 6.125 17.231 26.288 32.339 
Ratio 108 70.0 59.0 54.5 
For example, let us take Case 1 (as discussed above, allowing for 
a waiver of premium benefit) where a sickness claim is admitted only 
when a transition is made to state 2 (the development of full AIDS). 
Also, let Pt be the annual premium payable at time t = 0, 1, ... , n - l. 
Then the actuarial present value of annual premiums (APVP) is given 
by: 
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Table 3 
Present Value of PHI Benefits: Ao = Al = 0.10 
Defened Period: 
3 Months 
Polici' Terms {Years 2 5 10 15 20 
100 Al 6.092 21.527 33.260 40.081 
100 A, 63.091 150.480 206.611 233.975 
Ratio 10.4 7.18 6.18 5.84 
!ll = 0.01 
100 Al 6.026 20.793 32.223 38.545 
100 A, 62.129 146.437 198.228 224.077 
Ratio 10.3 7.04 6.15 5.81 
!ll = 0.05 
100 Al 5.745 18.916 28.203 32.804 
100 A, 58.097 130.326 170.037 187.542 
Ratio 10.1 6.88 6.03 5.72 
Defened Period: 
6 Months 
Polici' Terms {Years) 5 10 15 20 
!ll = 0.001 
100 Al 4.895 18.475 29.524 35.867 
100 A, 56.689 142.179 196.820 225.057 
Ratio 11.6 7.70 6.67 6.27 
!ll = 0.01 
100 Al 4.845 18.081 28.616 34.503 
100 A, 55.748 138.163 189.466 215.189 
Ratio 11.5 7.64 6.62 6.24 
!ll = 0.05 
100 Al 4.630 16.485 25.088 29.398 
100 A, 51.809 122.173 161.403 178.784 
Ratio 11.2 7.41 6.43 6.08 
If the deferred period were d 1 and the level of sickness benefit were 
B per annum for sickness of durations u where d 1 < u :::; d 1 + d z and 
the level of sickness benefit were C per annum « B) for sickness of 
durations u where u > d 1 + dz, then the actuarial present value of the 
benefits (APVB) under Case i (where i = 1,2) is given by 
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Table 4 
Present Value of PHI Benefits 
According to the Daykin et aI. (1988b) Model 
Deferred Period Six Months 
Terminating Age of Policy: 60 
Policy Terms (Years) 10 15 20 
Assumption A 
100 Al 0.67 1.76 2.18 
100A2 16.77 24.26 26.12 
Ratio 25.00 14.00 12.00 
Assumptions Be 
100 Al 0.48 1.02 1.28 
100 A2 9.49 13.88 15.25 
Ratio 20.00 14.00 12.00 
Assumptions F 
100 Al 0.65 1.36 1.71 
100 A2 6.88 9.33 10.11 
Ratio 11.00 7.00 6.00 
Note on assumptions made by Daykin et al. (1988b) 
A. 110' Ill' 113 England and Wales population mortality 
'Ao 0.7 at ages 25-50, reducing to zero at ages 15 and 70 
Be. 
F. 
'AI Max [exp( -8.4 + l.4d), 2.5] where d = duration in state 1 
112 Normal mortality +0.7 
Yo 0 





As for projection A 
As for projection A, but reducing linearly from 1987 to 
1992 to half initial intensity at all ages 
As for projection A 
As for projection A 
0.10 
As for projections A and Be 
As for projection Be 
As for projections A and Be 
Normal mortality +0.35 
As for projection Be 
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Table 4 (cont.) 
Present Value of PHI Benefits 
According to the Daykin et al. (1988b) Model 
Deferred Period Six Months 
Terminating Age of Policy: 65 
Policy Terms (Years) 10 15 20 
Assumption A 
100 Al 0.34 1.57 2.13 
100 A2 8.81 22.36 25.70 
Ratio 26.00 14.00 12.00 
Assumptions Be 
100 Al 0.25 0.90 1.25 
100 A2 4.71 12.13 14.83 
Ratio 19.00 13.00 12.00 
Assumptions F 
100 Al 0.38 1.25 1.65 
100 A2 3.96 8.54 9.93 
Ratio 10.00 7.00 6.00 
Note on assumptions made by Daykin et al. (1988b) 
A. flo, fll' fl3 England and Wales population mortality 
A,o 0.7 at ages 25-50, reducing to zero at ages 15 and 70 
A,I Max [exp( -804 + lAd), 2.5] where d = duration in state 1 
fl2 Normal mortality +0.7 
Yo 0 
Be. As for projection A 
As for projection A, but reducing linearly from 1987 to 
1992 to half initial intensity at all ages 





As for projection A 
As for projection A 
0.10 
As for projections A and Be 
As for projection Be 
As for projections A and Be 
Normal mortality +0.35 
As for projection Be 
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6 Emerging Costs 
These ideas also can be applied to emerging costs and cash flow 
considerations. For illustration, we choose a simplified example. We 
consider a nonprofit PHI policy for a term of n years with a zero de-
ferred period (to simplify the algebra). The policy has annual premiums, 
Pt , being paid at times t 0,1, ... , n 1. The premium is not paid if 
the policyholder is sick at time L. We use Case 1 for the definition of 
sickness for purposes of illustration. 
Let us take the benefits provided by the policy to be: 
• A death benefit of D t payable at the end of the policy year if the 
policyholder dies during the t-th policy year (for t = 1,2, ... , n); 
• An income benefit if Bt payable at the end of the t-th year if the 
policyholder is then alive and sick (for t = 1,2, ... , n). 
We assume that the rate of interest in the t-th policy year is it and that 
the expected cash flow for the t-th policy year per policy alive and in 
state j at the start of the t-th policy year is CFi j ). It follows that 
{ 
(1 + idPt -1 - pj2(l)Bt - PjJ,(l)Dt if j = 0 or 1 
cFi jj = -P22(I)Bt - P24(l)Dt if j = 2 
(1 + idPt -1 - P34(l)Dt if j = 3. 
Then, we define the expected costs (or cash flow) for the t-th policy 
year per policy originally issued to be ECt where 
3 ( 'j 
ECt = I CF/ POj(t - 1). 
j=O 
The above argument can be extended to allow for deferred periods, 
varying benefits, and transition intensities that are functions of attained 
age. If the Pts are net premiums (in the traditional sense of the term), 
then the equation of value for such a policy would, by definition, be 
given by 
00 I e- iit ECt = O. 
t=l 
This provides an extension to the results given by Hare and McCutcheon 
(1991) in respect to conventional life insurance profit testing. 
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7 Further Modifications to the Model 
7.1 Separating Incidence of Disability 
The discussion earlier is based on the model depicted in Figure 2 
and considers the two extreme cases (Case 1 and Case 2) of timing of a 
claim for disability income from a PHI policy. A more satisfactory ap-
proach is to recognize explicitly the existence of an intermediate state 
between HIV positive and AIDS for those who are sick and, hence, eligi-
ble for a claim. Figure 3 depicts the new model needed, with the states 
renumbered and the transition intensities as shown. A PHI claim would 
be accepted once a policyholder has entered state 2 (and the income 
benefit would be payable while he/she occupies either states 2 or 3). 
Figure 3 
Modified AIDS Model (Version 2) 
Clear At Risk ~ HIV + '\. Sick '\. AIDS / -, 
(4) vi (0) A (1) A, (2) A (3) 0 1-0 
,I,. ftt ,I,. to 
," ?-' ,Vt'J. 'v (3 
Dead (5) 
This approach leads to no conceptual difficulties. We still must de-
velop the Chapman-Kolmogorov system of differential equations and 
solve for the transition probabilities Pij(t). The solutions are similar 
to that given in equations (1) to (6); see Ramsay (1989). For example, 
(17) 
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(18) 
where (Xo = Vo + 110 + i\o, (Xl = i\l + 111 and (X2 = i\2 + 112. 
To deal with sickness claims that are paid while the policyholder is 
in state 2 or state 3 in the presence of a deferred period d, we define 
Sd (t) to be the probability that a person in state 0 at time 0 is always 
in state 2 or state 3 during the time interval [t - d, tJ. Then as for 
equations (8) and (9), we obtain 
rt - d 
Sd(t) = Jo POdU)(P22(t - u) + PZ3(t - u))i\ldu, for t > d. (19) 
Substitution from equations (5), (17), and (18) leads to the following: 
i\oe-J1zt [1 -e-(CXj-cxz)(t-d) _ (1 - e-(CXo-CXZ)(t-d))] 
((Xo - (Xl) ((Xl - (X2) ((Xo - (X2) 
+ i\oe-J13t [i\l (1 - r(cx j-J13)(t-d)) 
((Xo - (Xd((X2 - 113) ((Xl - 113) 
_ i\2(l - e-(CXO- J13 )(t-d))] 
((Xo - 113) 
_ i\0i\2e-cxzt [(1_r(CX 1-CX2 )(t-d)) 
((Xo - (Xd((X2 - 113) ((Xl - (X2) 
(1 - r(cxo-cxz)(t-d)) ] 
((Xo - (X2) . (20) 
The actuarial present value of a PHI benefit of one unit (per year) in 
an n year policy with deferred period of d would be: 
A3(n,d) f: e-r5tsd(t)dt 
i\0i\dI12 - 113)(e-(8+cx2 )d - e-(8+cx2 )n) 
((X2 - 113)((XI - (Xz)((Xo - (X2)(8 + (X2) 
i\0i\1i\2 (e-(8+J13)d - e-(O+J13)n) 
+ ----~~~--------------~--
((X2 - 113)((XI - 113)((Xo - 113)(8 + 113) 
i\0i\dI12 - 113)e(CX j-cxz)d(e-(O+cxj}d - e-(o+cx1)n) 
((Xo - (Xd((Xl - (XZ)((X2 - 113)(8 + (Xl) 
i\0i\1 (112 - 113)e(CXo-cxz)d(e-(o+cxo)d - e-(o+cxo)n) 
+ ~~~--~~----~--------~----~ 
((Xo - (Xd ((Xo - (X2)((X2 - fJ3)(8 + (Xo) 
i\0i\1 i\2e(CX1-J13)d (e-(O+cxj}d - e-(o+cx1)n) 
((Xo - (Xl)((X2 - 113)((XI - 113)(8 + (Xl) 
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As an illustration of the numerical effect of separating the incidence 
of disability and receipt of the income benefit from the onset of AIDS, 
we present some sample values of A3 (n, d) in Table 5. 
Table 5 
Present Value of PHI Benefits: Modified Model 
Values of 100 A3 
Deferred Period: Three Months 
Policy Terms (Years) 
!:!I !:!? AI 11,2 5 10 15 20 
0.01 0.05 0.1 0.1 8.702 37.190 66.396 86.776 
0.01 0.05 0.1 0.2 8.454 34.488 58.916 74.394 
0.01 0.05 0.2 0.1 15.577 60.273 99.365 122.436 
0.01 0.05 0.2 0.2 15.121 55.690 87.587 104.136 
0.05 0.10 0.1 0.1 7.784 30.408 50.480 62.490 
0.05 0.10 0.1 0.2 7.600 28.602 45.928 55.514 
0.05 0.10 0.2 0.1 13.962 49.696 76.950 90.890 
0.05 0.10 0.2 0.2 13.622 46.619 69.704 80.376 
Deferred Period: Six Months 
Policy Terms (Years) 
!:!I !:!2 AI 11,2 5 10 15 20 
0.01 0.05 0.1 0.1 7.384 34.163 62.369 82.265 
0.01 0.05 0.1 0.2 7.139 31.467 54.898 69.892 
0.01 0.05 0.2 0.1 13.289 55.606 93.641 116.331 
0.01 0.05 0.2 0.2 12.837 51.032 81.874 98.043 
0.05 0.10 0.1 0.1 6.563 27.743 47.066 58.757 
0.05 0.10 0.1 0.2 6.380 25.942 42.519 51.788 
0.05 0.10 0.2 0.1 11.833 45.521 71.942 85.607 
0.05 0.10 0.2 0.2 11.496 42.450 64.705 75.102 
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We retain the parameter values used in earlier tables (/10 = /14 = 
0.001, Vo = 0.10, 0 = 0.07, /13 = 0.35); we focus on Ao = 0.10 for direct 
comparison with Tables 3 and 4. Values have been chosen such that 
(Xi '* (X j for i '* j. As expected, the values of A3 (n, d) are intermediate 
between the two extreme estimates of Ai (n, d) al!d Az (n, d) presented 
earlier. We note the extent to which A3 (n, d) increases with increasing 
n and decreases with increasing d, decreases with increasing forces of 
mortality, and its relative sensitivity to the choice of Ai and relative 
insensitivity to the choice of Az. As expected, A3 (n, d) increases with 
increasing Ai (representing the rate of flow into the claiming state) and 
decreases with increasing Az (representing part of the rate of flow out of 
the claiming state). Space constraints prevent pursuing the sensitivities 
of A3 (n, d) further. 
7.2 Dependence on Time of Occupancy 
It would be more realistic to allow some transition intensities to de-
pend on the time spent in the current state since the latest transition 
into that state. This idea of duration dependence leads to the introduc-
tion of semi-Markov processes (Cox and Miller, 1965). 
The semi-Markov process can be described by a pair of continuous 
time stochastic processes {S(x),Z(x)} for x ~ O. Let S(x) represent 
the state of an individual at time (or age) x where S(x) E 1,2, ... , k. Let 
Z(x) denote the duration for an individual at time x of the temporary 
stay so far in the current state, Le., 
Z(x) = max{z : z :s; x and S(x - u) = S(x) for all u E [0, z]}. 
The event {S (x) = j n Z (x) = z} represents an individual being in state 
j at time x with a duration of z since the last transition into state j. 
We can follow the approach of Section 3 and define transition inten-
sities and probabilities and construct equations for the latter (which will 
be mixed integro-differential equations). The resulting expressions are 
complex. A useful approximation to the semi-Markov model is to follow 
the suggestion of Cox and Miller (1965) and introduce a number of sub-
states; this has been applied to actuarial problems by Norberg (1988) in 
considering select survival models and by Jones (1994) in considering 
multiple state models. 
The replacement of a state by a pair of states labeled "stable" and 
"unstable" together with the transition intensities that are independent 
of the time spent within each substate mimics approximately the be-
havior of a semi-Markov model. Figure 4 illustrates part of such a 
I 
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model structure where we seek to approximate a duration dependence 
for transition from state 1 to state 2. State 1 becomes "HIV positive: 
unstable", and we add a further state 6, "HIY positive: stable". This 
modification can be implemented for the model discussed earlier and 
depicted in Figures 2 and 3. 
Figure 4 
Part of Modified AIDS Model (Version 3) 
HIV + Unstable Sick 
.... 
, (1) , (2) , 
\11 II' 
II HIV+ Stable I 
(6) 
,II 
Dead I (5) 
Another approximation that can be made is to model nonconstant 
intensity functions as piecewise constant functions. This preserves the 
mathematical tractability of constant forces while giving the flexibil-
ity of using nonconstant functions. For a further discussion, readers 
are referred to Cox and Miller (1965) and to Jones (1994) for actuarial 
applications. 
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